InvestorsHub Logo
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

Re: crudeoil24 post# 94

Friday, 03/09/2018 1:20:08 PM

Friday, March 09, 2018 1:20:08 PM

Post# of 179
CHRS had its 4Q17 earnings release and CC yesterday and said that the FDA accepted CHRS' proposed assay to measure immunogenicity of the company's Neulasta FoB.

I'm surprised the stock is up so much today. FDA acceptance of the proposed assay is not the same as FDA acceptance of the assayed immunogenicity data, which is the issue of consequence for this program.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CHRS News